Anthony Czaplicki, MD
Orthopaedic Surgery · Newburgh, INNPI 1104083823
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $27,750 of the $37,552 with a category attached, or 73.9%. Encore Medical, LP accounts for 73.9% of it on its own, with 3 other manufacturers making up the rest.
Across 61 payments — averaging $615.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Encore Medical, LP$28K
- Zimmer Biomet$10K
- Johnson & Johnson$31
- Avanos Medical$18
Across 14 payments — averaging $1317.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$18K
What the payments were for
- Royalty or licence$27,75074%
- Travel & lodging$7,89421%
- Food & beverage$1,8145%
- Education$940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Encore Medical, LP | 11 | $27,750 |
| Zimmer Biomet | 48 | $9,752 |
| Johnson & Johnson | 1 | $31 |
| Avanos Medical | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO SURGICAL$111,002
- ROSA$4,932
- Persona Revision$1,444
- Connected Health-None$605
- Persona$523
- Arcos$459
- mymobility Platform$263
- Accelero-None$139
- ROSA-Knee$139
- Avenir$139
- RHK$122
- Arcos Revision$122
- Revision$122
- OSS$122
- LCCK NexGen$122
How this compares
$37,552 in reported general payments places this provider in the 85th percentile of 400 orthopaedic surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $7,616 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 166 | $2,046 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 98 | $1,081 |
| Methylprednisolone | 85 | $515 |
| Celecoxib | 15 | $440 |
| Meloxicam | 247 | $439 |
| Amoxicillin | 208 | $289 |
| Diclofenac Sodium | 15 | $289 |
| Oxycodone Hcl | 25 | $246 |
| Tramadol Hcl | 98 | $240 |
| Ondansetron Hcl | 36 | $179 |
| Ibuprofen | 27 | $162 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $134 |
| Cephalexin | 22 | $117 |
| Clindamycin Hcl | 44 | $106 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Newburgh
- Douglas LoweryNewburgh$53K
- Frank KolisekGreenwood$7.5M
- David FisherIndianapolis$5.9M
- Michael BerendIndianapolis$4M
- John WilliamsFort Wayne$2.7M
- Sanford KunkelIndianapolis$1.9M
- Hill HastingsIndianapolis$1.6M
- Mark KlaassenElkhart$1.3M
- Alan McGeeFort Wayne$1.1M
- Lindsey RolstonNew Castle$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.